Embryonal rhabdomyosarcoma of the head and neck in children.
D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004428:Ear Neoplasms / Q000628:therapy; D005260:Female; D006257:Head; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007223:Infant; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D008441:Maxillary Neoplasms / Q000628:therapy; D009303:Nasopharyngeal Neoplasms / Q000628:therapy; D009362:Neoplasm Metastasis; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D010307:Parotid Neoplasms / Q000628:therapy; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012888:Skull Neoplasms / Q000628:therapy; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide